U.S. markets closed
  • S&P Futures

    4,270.75
    -6.00 (-0.14%)
     
  • Dow Futures

    33,933.00
    -30.00 (-0.09%)
     
  • Nasdaq Futures

    13,463.50
    -29.75 (-0.22%)
     
  • Russell 2000 Futures

    1,989.20
    +0.10 (+0.01%)
     
  • Crude Oil

    88.08
    -0.03 (-0.03%)
     
  • Gold

    1,780.60
    +3.90 (+0.22%)
     
  • Silver

    19.75
    +0.01 (+0.07%)
     
  • EUR/USD

    1.0188
    +0.0008 (+0.08%)
     
  • 10-Yr Bond

    2.8930
    +0.0690 (+2.44%)
     
  • Vix

    19.90
    +0.21 (+1.07%)
     
  • GBP/USD

    1.2047
    -0.0004 (-0.03%)
     
  • USD/JPY

    134.8430
    -0.2470 (-0.18%)
     
  • BTC-USD

    23,431.94
    -532.37 (-2.22%)
     
  • CMC Crypto 200

    557.35
    -15.47 (-2.70%)
     
  • FTSE 100

    7,515.75
    -20.31 (-0.27%)
     
  • Nikkei 225

    28,944.25
    -278.52 (-0.95%)
     

Free Technical Reports on Myriad Genetics and Three Additional Services Equities

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Stock Research Monitor: CDNA, QGEN, and NXTD

LONDON, UK / ACCESSWIRE / June 21, 2018 / If you want a free Stock Review on MYGN sign up now at www.wallstequities.com/registration. On Wednesday, the NASDAQ Composite ended the day at 7,781.51, up 0.72%; the Dow Jones Industrial Average edged 0.17% lower, to finish at 24,657.80; and the S&P 500 closed at 2,767.32, marginally gaining 0.17%. US markets saw seven out of nine sectors finishing the day in green, one in red, and one in neutral territory. WallStEquities.com has initiated research reports on the following Services stocks: CareDx Inc. (CDNA), Myriad Genetics Inc. (MYGN), QIAGEN N.V. (QGEN), and Nxt-ID Inc. (NXTD). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

CareDx

Brisbane, California headquartered CareDx Inc.'s stock finished Wednesday's session 5.51% lower at $14.74 with a total trading volume of 569,113 shares, which was higher than their three months average volume of 518.93 thousand shares. The stock has gained 28.17% in the past month, 143.23% over the past three months, and 1,252.29% in the previous twelve months. The Company's shares are trading above their 50-day and 200-day moving averages by 26.99% and 101.82%, respectively. Moreover, shares of CareDx, which together with its subsidiaries, engages in the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients worldwide, have a Relative Strength Index (RSI) of 63.04.Get the full research report on CDNA for free by clicking below at:

www.wallstequities.com/registration/?symbol=CDNA

Myriad Genetics

Shares in Salt Lake City, Utah headquartered Myriad Genetics Inc. declined 1.19%, ending yesterday's session at $39.05 with a total trading volume of 621,632 shares. The stock has gained 27.16% in the previous three months and 55.89% over the past twelve months. The Company's shares are trading above their 50-day and 200-day moving averages by 16.01% and 16.37%, respectively. Moreover, shares of Myriad Genetics, which focuses on developing and marketing novel predictive medicine, personalized medicine, and prognostic medicine tests worldwide, have an RSI of 63.55. Today's complimentary research report on MYGN is accessible at:

www.wallstequities.com/registration/?symbol=MYGN

QIAGEN

On Wednesday, Venlo, the Netherlands headquartered QIAGEN N.V.'s stock saw a drop of 0.25%, to close the day at $36.43. A total volume of 341,231 shares was traded. The Company's shares have advanced 8.42% in the previous three months. The stock is trading above its 50-day and 200-day moving averages by 4.50% and 9.71%, respectively. Additionally, shares of QIAGEN, which provides sample to insight solutions that transform biological materials into molecular insights worldwide, have an RSI of 54.66. Register now for your free research document on QGEN at:

www.wallstequities.com/registration/?symbol=QGEN

Nxt-ID

Shares in Melbourne, Florida-based Nxt-ID Inc. ended the day 5.52% higher at $1.72. A total volume of 486,350 shares was traded, which was above their three months average volume of 359.79 thousand shares. The stock has gained 24.64% over the last twelve months. The Company's shares are trading below their 50-day moving average by 8.62%. Furthermore, shares of Nxt-ID, which engages in the development of products and solutions for security, healthcare, financial technology, and IoT markets, have an RSI of 43.96. Click on the link below and see our free report NXTD at:

www.wallstequities.com/registration/?symbol=NXTD

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities